Gastrointestinal pathophysiology and nutrition in cystic fibrosis

被引:23
|
作者
Ratchford, Thomas L. [1 ]
Teckman, Jeffrey H. [1 ]
Patel, Dhiren R. [1 ]
机构
[1] St Louis Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, 1465 S Grand Blvd, St Louis, MO 63104 USA
关键词
Cystic fibrosis transmembrane conductance regulator (CFTR); cystic fibrosis; enteral nutrition; failure to thrive; growth failure; malabsorption; nutrition; Pancreatic enzyme replacement therapy (PERT); pancreatic insufficiency; vitamin deficiency; LUNG-FUNCTION; BODY-COMPOSITION; GROWTH; GUIDELINES; MANAGEMENT; IVACAFTOR; DIAGNOSIS; CHILDREN; OUTCOMES; CFTR;
D O I
10.1080/17474124.2018.1502663
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Cystic fibrosis (CF) is a severe, progressive, multisystemic disease that is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene. Optimizing nutrition is critical, as higher growth parameters are associated with better pulmonary function and outcomes, but unfortunately patients with this disease are prone to malnutrition, growth failure, and vitamin deficiencies. The purpose of this review is to provide a timely highlight of the physiologic processes and outcome data to support today's management strategies, as well as review these principles themselves.Areas covered: This review covers the background of the importance of vigilant attention to nutrition and growth in these patients, the underlying physiology leading to an abnormal gastrointestinal tract and its role in CF malnutrition, and current evaluation and management strategies to address nutrition in CF. Analysis of up-to-date relevant literature was performed using PubMed.Expert commentary: Advances in research and clinical developments over the years have improved knowledge of this disease as well as patient outcomes. Of particular importance is optimizing nutrition especially in the early stages of life, as well as accounting for the markedly abnormal CF intestinal milieu when addressing the gastrointestinal and nutritional needs of these patients.
引用
收藏
页码:853 / 862
页数:10
相关论文
共 50 条
  • [2] Gastrointestinal and Nutrition Implications in Cystic Fibrosis
    McDonald, Catherine M.
    Pohl, John F.
    PRACTICAL GASTROENTEROLOGY, 2024, 48 (04) : 34 - 43
  • [3] PATHOPHYSIOLOGY OF GASTROINTESTINAL COMPLICATIONS OF CYSTIC-FIBROSIS
    BOROWITZ, D
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 15 (05) : 391 - 401
  • [4] Drosophila as a model for studying cystic fibrosis pathophysiology of the gastrointestinal system
    Kim, Kevin
    Lane, Elizabeth A.
    Saftien, Aurelia
    Wang, Haiyun
    Xu, Yue
    Wirtz-Peitz, Frederik
    Perrimon, Norbert
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (19) : 10357 - 10367
  • [5] Year in review 2020: Nutrition and gastrointestinal disease in cystic fibrosis
    Sathe, Meghana
    Sharma, Preeti B.
    Savant, Adrienne P.
    PEDIATRIC PULMONOLOGY, 2021, 56 (10) : 3120 - 3125
  • [6] GENETIC MARKERS AND MODIFIERS OF GASTROINTESTINAL DISEASE AND NUTRITION IN CYSTIC FIBROSIS
    Durie, Peter R.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 124 - 125
  • [7] Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy
    McDonald, Catherine M.
    Reid, Elizabeth K.
    Pohl, John F.
    Yuzyuk, Tatiana K.
    Padula, Laura M.
    Vavrina, Kay
    Altman, Kimberly
    NUTRITION IN CLINICAL PRACTICE, 2024, 39 : S57 - S77
  • [8] Pathophysiology and therapy of cystic fibrosis
    Bachert, C
    HNO, 1996, 44 (04) : 167 - 168
  • [9] Pancreatic pathophysiology in cystic fibrosis
    Gibson-Corley, Katherine N.
    Meyerholz, David K.
    Engelhardt, John F.
    JOURNAL OF PATHOLOGY, 2016, 238 (02): : 311 - 320
  • [10] PULMONARY PATHOPHYSIOLOGY IN CYSTIC FIBROSIS
    BEIER, FR
    RENZETTI, AD
    MITCHELL, M
    WATANABE, S
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1966, 94 (03): : 430 - &